Stocks and Investing
Stocks and Investing
Tue, January 19, 2016
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, January 15, 2016
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, January 14, 2016
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Gregg Gilbert Maintained (TEVA) at Strong Buy with Decreased Target to $81 on, Jan 14th, 2016
Gregg Gilbert of Deutsche Bank, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Strong Buy with Decreased Target from $82 to $81 on, Jan 14th, 2016.
Gregg has made no other calls on TEVA in the last 4 months.
There are 2 other peers that have a rating on TEVA. Out of the 2 peers that are also analyzing TEVA, 0 agree with Gregg's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Gregg
- Irina Rivkind Koffler of "Mizuho" Initiated at Strong Buy and Held Target at $79 on, Monday, December 7th, 2015
- Rohit Vanjani of "Guggenheim" Upgraded from Hold to Strong Buy on, Friday, December 4th, 2015
Contributing Sources